Status:
COMPLETED
Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer
Lead Sponsor:
Samsung Medical Center
Collaborating Sponsors:
Olympus
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Background: Pancreatic cancer is associated with a poor prognosis. Therefore, rapid and accurate diagnosis of a pancreatic mass is important to direct patient management. Endoscopic ultrasonography-g...
Detailed Description
Patient: Newly diagnosed pancreatic cancer patient whose cancer lesion is suspected unresectable in diagnostic imaging such as CT or MRI Procedure: Each EUS-guided FNA and ProCore aspiration will p...
Eligibility Criteria
Inclusion
- Patients who agree to participate in research
- 18 years of age and older patients less than 80 years old
- Patients who have suspected unresectable pancreatic cancer in imaging studies
Exclusion
- Contraindication to endoscopy
- Patients younger than 18 years old or older than 80 years old
- Bleeding tendency
- Cardiopulmonary dysfunction
- Pregnancy
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT01876069
Start Date
July 1 2013
End Date
February 1 2015
Last Update
April 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710